Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 14, 2026
Strategy Inc. (MSTR) Down ~78% From Highs: Path Back to $200?

Strategy Inc. (MSTR) Down ~78% From Highs: Path Back to $200?

Key Takeaways

  • Target in focus: Strategy Inc. (NASDAQ: MSTR) currently trades near $92, and investors are asking whether the stock can reclaim the $200 level — a psychologically significant round number it last touched in May 2026.
  • Strongest bullish factor: Strategy holds over 843,000 Bitcoin (BTC), making it the world's largest corporate BTC holder. Any sustained Bitcoin rally would directly lift the value of its treasury and likely drive the stock higher.
  • Biggest obstacle: Share dilution has been relentless. The outstanding share count has ballooned from roughly 77 million in 2021 to over 350 million, diluting per-share value even as total Bitcoin holdings grew.
  • Key resistance levels: The $100 mark is the first major psychological and technical hurdle, followed by $104.27, where the recent rally stalled. Beyond that, $136 serves as the next significant resistance zone.
  • Investor takeaway: Reaching $200 is plausible but hinges almost entirely on a sustained Bitcoin recovery and disciplined capital management that limits further dilution.

Why Investors Are Watching the $200 Level

Strategy Inc., the company formerly known as MicroStrategy, has become synonymous with corporate Bitcoin adoption. Under the leadership of founder Michael Saylor, the firm transformed from an enterprise analytics software provider into a Bitcoin treasury powerhouse. The stock currently trades around $92, down roughly 78% from its 52-week high and sharply below the $200 level it briefly reclaimed earlier in 2026. For many investors, $200 represents both a recovery milestone and a test of whether the Bitcoin treasury model can regain market confidence after a punishing drawdown.

The $200 target is not arbitrary. It aligns with several Wall Street price targets, including Mizuho's $213, Texas Capital's $225, and BTIG's $250. It is also a round-number psychological level that traders and algorithms tend to cluster around, making it a natural magnet if upward momentum returns.

Current Market Position

Strategy's Q1 2026 results underscored the binary nature of the investment. Revenue from the legacy software business grew 11.9% year-over-year to $124.3 million — a respectable showing — but that figure was dwarfed by a $14.47 billion operating loss driven by unrealized markdowns on digital asset holdings. The software business, while steady, is now little more than a footnote. The stock trades as a leveraged proxy for Bitcoin, and that linkage defines virtually every price swing.

As of mid-2026, Strategy holds approximately 843,775 BTC. The company recently sold 3,588 Bitcoin for around $216 million — its first meaningful BTC sale — to build a U.S. dollar reserve and fund preferred dividend obligations. That move, while unsettling to some bulls, was viewed by firms like Grayscale Research as a sign of financial discipline rather than distress. Strategy now holds roughly $2.55 billion in cash reserves, covering an estimated 17 months of preferred dividend payments.

What Could Drive the Next Leg Higher

The path to $200 runs almost exclusively through Bitcoin. If the cryptocurrency mounts a sustained recovery — driven by improving macroeconomic conditions, regulatory clarity, or renewed institutional inflows — Strategy's treasury value would expand accordingly. Historically, MSTR has amplified Bitcoin's moves in both directions, and a strong BTC rally could quickly pull the stock toward the $136–$160 range, with $200 coming into view if momentum persists. I also checked this using Tickeron’s AI Trend Prediction Engine to gauge the broader technical setup.

A second catalyst would be S&P 500 inclusion. Several market commentators argue that Strategy's recent moves to strengthen its balance sheet — building dollar reserves, repurchasing convertible debt, and demonstrating the ability to generate liquidity during Bitcoin weakness — address concerns previously raised by S&P Global. Inclusion would force passive index funds to purchase MSTR shares, creating a structural demand floor that could accelerate any recovery.

Analyst sentiment remains broadly constructive. Of the analysts covering the stock, approximately 90% maintain Buy-equivalent ratings. The median 12-month price target sits near $245, implying the professional consensus already anticipates a move above $200 over the coming year.

What Could Prevent the Move

The most significant headwind is dilution. Strategy has funded its Bitcoin accumulation through aggressive equity issuance, and the outstanding share count has surged from roughly 77 million in 2021 to over 350 million by 2026. Every new share sold to purchase Bitcoin dilutes existing holders, meaning the per-share Bitcoin exposure may not grow even as the total BTC stash expands. If this pattern continues, a rising Bitcoin price may not translate into proportional per-share gains.

The modified net asset value (mNAV) premium has also compressed sharply. At its peak in 2025, the stock traded at roughly 2.7 times the market value of its Bitcoin holdings. That premium has since collapsed, and any further deterioration in market confidence could keep MSTR trading at or below the value of its underlying BTC — limiting upside even in a Bitcoin bull market.

Technically, the stock faces a gauntlet of resistance. The $100 level, formerly support, now acts as a ceiling. A bear flag pattern visible on daily charts suggests the recent bounce may be corrective rather than the start of a new uptrend. A failure to clear $104.27 — the 0.382 Fibonacci retracement that stalled the last rally — would keep the bears in control.

Technical Levels That Matter

Immediate resistance sits at $100, with $104.27 representing the first major test of bullish conviction. Above that, $136 marks the next significant zone. On the downside, $94.41 is near-term support, followed by $84.55. A breakdown below the June low of approximately $81.58 would expose the stock to further declines toward the $70 area. The stock also trades below both its 50-day and 200-day moving averages, confirming a bearish intermediate-term trend that any rally toward $200 would need to reverse.

Analyst Opinions and Price Targets

Wall Street remains predominantly bullish despite the steep selloff. Mizuho recently trimmed its target to $213 while maintaining an Outperform rating. Barclays initiated coverage with an Overweight rating and a $130 target in early July 2026. BTIG kept a Buy rating with a $250 target, arguing that Strategy's capital structure will enable it to outperform Bitcoin as prices recover. Texas Capital raised its target to $225. The average 12-month target across all covering analysts sits in the $245–$314 range, putting $200 firmly within the consensus expectation.

Leveraging AI Daily Buy/Sell Signals for Timely Insights

Navigating a stock as volatile as MSTR requires timely, data-driven insight. I frequently rely on Tickeron's AI Daily Buy/Sell Signals in my own monitoring process. These AI-powered tools continuously scan thousands of stocks and ETFs, delivering Buy, Sell, or Hold signals based on technical patterns and market shifts. They help me stay on top of evolving conditions without spending hours reviewing charts manually, which is especially useful when tracking whether a name like this can sustain momentum toward key levels such as $200.

Final Assessment

Can Strategy stock reach $200? The answer is a qualified yes — but the path is narrow and conditional. A sustained Bitcoin recovery above $70,000–$80,000 would likely be sufficient to pull MSTR toward the $160–$200 range, provided the company does not aggressively dilute shareholders in the process. Analyst consensus already embeds a $200+ outcome within the next 12 months. However, the risks are real: dilution, compressed mNAV premiums, and a fragile technical structure all stand in the way. Investors should monitor Bitcoin price action, quarterly filings for share count changes, and whether the stock can decisively reclaim the $100–$104 resistance zone as the first meaningful signal that a move toward $200 is underway.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MSTR

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for MSTR turns negative, indicating new downward trend

MSTR saw its Momentum Indicator move below the 0 level on August 13, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned negative. In of the 76 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where MSTR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MSTR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MSTR advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.238) is normal, around the industry mean (28.717). P/E Ratio (5.299) is within average values for comparable stocks, (82.489). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.745). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (61.728) is also within normal values, averaging (77.023).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MSTR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MSTR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.47B. The market cap for tickers in the group ranges from 291 to 234.43B. SAP holds the highest valuation in this group at 234.43B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was -0%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 10%. TEAM experienced the highest price growth at 51%, while NXTT experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was -21%. For the same stocks of the Industry, the average monthly volume growth was 18% and the average quarterly volume growth was -41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 76
Price Growth Rating: 56
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
MSTR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of e-business software and services

Industry PackagedSoftware

Profile
Details
Industry
Internet Software Or Services
Address
1850 Towers Crescent Plaza
Phone
+1 703 848-8600
Employees
1539
Web
https://www.strategy.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Strategy Inc. (MSTR) Down ~78% From Highs: Path Back to $200?